BSECompany Update3d ago
Syngene International Ltd
Grant of Performance Share Units under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 ("Plan")
Syngene International Ltd has granted 14,26,061 Performance Share Units to eligible employees under the Syngene Long Term Incentive Performance Share Plan 2023.
BSECompany Update25 Aug 2026
Syngene International Ltd
Intimation of Schedule of Investor/Analyst Meeting with Goldman Sachs Asia Leaders Conference 2026
Syngene International Ltd has announced a meeting with Goldman Sachs Asia Leaders Conference 2026, scheduled for August 31 and September 1, 2026, in Hong Kong. The company will not disclose any unpublished price-sensitive information during the meeting.
BSECompany UpdateExpansion24 Aug 2026
Syngene International Ltd
Intimation of investment in Ampin C&I Power Twelve Private Limited
Syngene International Ltd has acquired an equity stake in Ampin C&I Power Twelve Private Limited for renewable power generation, aligning with its renewable energy objectives and decarbonization goals.
BSECompany UpdateMgmt Change24 Aug 2026
Syngene International Ltd
Intimation of Investor call schedule with Entrust Family Office
Syngene International Ltd has announced an investor call schedule with Entrust Family Office on August 28, 2026, and has stated that no unpublished price-sensitive information will be disclosed during the meeting.
BSECompany UpdateMgmt Change10 Aug 2026
Syngene International Ltd
Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.
Syngene International Ltd has announced a meeting with analysts and institutional investors on August 13 and 14, 2026, organized by Emkay Global. The company will not disclose any unpublished price sensitive information during the meeting.
BSECompany UpdateResults6 Aug 2026
Syngene International Ltd
Intimation of Earnings Conference call transcript for Q1 FY2027
Syngene International Ltd has announced the transcript of its Q1 FY2027 Earnings Conference call, which is available on the company's website.
BSEAGM/EGMResults31 Jul 2026
Syngene International Ltd
Scrutinizer''s Report and voting results of 33rd Annual General Meeting
Syngene International Ltd's 33rd Annual General Meeting (AGM) voting results and Scrutinizer's Report have been submitted. All 9 resolutions were approved with the requisite majority by the shareholders. The details of votes cast by shareholders are given in the attached Annexure A. The results of e-voting along with Scrutinizer's Report are also available on the Company's website and on the website of Kfin Technologies Limited, the Register and Share Transfer Agents.
BSECompany UpdateResults30 Jul 2026
Syngene International Ltd
Intimation of audio recording for Q1 FY27 post-earnings call
Syngene International Ltd has announced the availability of the audio recording of its Q1 FY27 post-earnings call, which was conducted on July 30, 2026, and uploaded on the company's website.
BSECompany UpdateResults30 Jul 2026
Syngene International Ltd
Newspaper Advertisement - Financial Results
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue at ₹7,360 crore, profit before tax at ₹4,875 crore, and profit after tax at ₹1,013 crore.
BSECompany UpdateResults29 Jul 2026
Syngene International Ltd
Investor Presentation
Syngene International Ltd has released an investor presentation for Q1 FY27, highlighting a 16% Y-o-Y decline in revenue from operations to Rs 736 Cr, with EBITDA margin at 12% (24% in Q1 FY26). The company has strengthened its AI-enabled scientific platform, Syngene's AI-enabled scientific platform for accelerating drug discovery services, and has been recognized as one of the world's top 750 most sustainable companies for the second consecutive year.
BSEAGM/EGMResults29 Jul 2026
Syngene International Ltd
Proceedings of the 33rd Annual General Meeting
Syngene International Ltd held its 33rd Annual General Meeting on July 29, 2026, through video conferencing, where 117 members were present. The meeting approved the audited financial statements for the year ended March 31, 2026, and declared a final dividend of Rs. 1.25 per equity share.
BSECompany UpdateMgmt Change29 Jul 2026
Syngene International Ltd
Resignation of Independent Director
Syngene International Ltd announced the resignation of Independent Director Mr. Kush Parmar, effective July 29, 2026, due to increasing commitments in the USA and inability to devote sufficient time to the Company.
BSECompany Update▼ NegativeResults29 Jul 2026
Syngene International Ltd
Press Release
Syngene International Limited announced its Q1 FY27 results, with revenue from operations at Rs. 736 Cr and operating EBITDA at Rs. 91 Cr. The company's performance was impacted by the lack of offtake from a major biologics client and forex hedge loss. Despite this, the company maintains a strong balance sheet and financial discipline, which provides flexibility to invest in strategic priorities.
BSEResult▼ NegativeResults29 Jul 2026
Syngene International Ltd
Results - Financial Results for quarter ended June 30, 2026
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026. The company reported a profit before tax of Rs. (192) million and a profit for the period of Rs. (90) million. The results also include a net loss of Rs. (135) million from exceptional items.
BSEBoard MeetingResults29 Jul 2026
Syngene International Ltd
Outcome of the Board Meeting held on July 29, 2026
Syngene International Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 6,630 million and a net profit of Rs. 21 million. The company's consolidated revenue from operations was Rs. 7,360 million, with a net profit of Rs. 90 million.
BSECompany UpdateResults22 Jul 2026
Syngene International Ltd
Intimation of Conference Call with Analysts and Investors.
Syngene International Ltd has announced a conference call with analysts and investors to discuss Q1 FY 2026-27 financial results on July 30, 2026.
BSEInsider Trading / SASTRegulatory22 Jul 2026
Syngene International Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund
Syngene International Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Mirae Asset Mutual Fund.